Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Open Access Maced J Med Sci ; 7(15): 2502-2507, 2019 Aug 15.
Article in English | MEDLINE | ID: mdl-31666855

ABSTRACT

BACKGROUND: Nasopharyngeal Angiofibroma is a rare neoplasm in the sphenopalatine foramen. This tumour is histologically benign, but clinically malignant because it can erode the bone and surrounding structures, such as the pterygopalatine fossa, paranasal sinuses, and nasal cavity. It is a highly vascular tumour, sometimes from multiple Feeding arteries, and tends to bleed easily. CASE PRESENTATION: In these cases, series, we reported four cases of nasopharyngeal angiofibroma in children and one case in an elderly patient. The diagnosis was made by history taking, physical examination and Cerebral MSCT Angiography, as well as Digital Subtraction Angiography (DSA). After identification of the Feeding artery, we performed transarterial embolisation using polyvinyl alcohol (PVA) foam particles. CONCLUSION: Preoperative embolisation in the highly vascular tumour, such as nasopharyngeal angiofibroma, is very useful to reduce peri-operative complication of surgery. This procedure can reduce blood loss during resection of the tumour and gives better outcomes.

2.
Microbiol Immunol ; 59(6): 322-30, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25890990

ABSTRACT

Leptospirosis is a worldwide zoonosis. The importance of urban leptospirosis is recognized in Japan: urban rats carry pathogenic leptospires and people acquire these pathogens through contact with surface water or soil contaminated by the urine of the infected animals. To determine the current Leptospira carriage rate in urban rats, 29 wild rats were trapped in the central area of Fukuoka and strains isolated from their kidneys and urine analyzed. When semi-solid Korthof's medium containing 0.1% agar was used for isolation, 72.2% and 30.8% of the kidney and urine cultures, respectively, were found to be Leptospira-positive. The isolates belonged to Leptospira interrogans, and were classified into two groups (serogroups Pomona and Icterohaemorrhagiae) based on the results of gyrB sequence analysis and microscopic agglutination testing (MAT). Strains belonging to serogroup Icterohemorrhagiae grew well in liquid medium. On the other hand, serogroup Pomona isolates multiplied very little in liquid medium, but did grow in a semi-solid medium. Although strains belonging to serogroup Pomona have not been recognized as native to Japan, this strain may be widely distributed in urban rats. Representative strains from each group were found to be highly pathogenic to hamsters. Our findings should serve as a warning that it is still possible to become infected with leptospires from wild rats living in inner cities of Japan. Furthermore, the use of semi-solid medium for culture will improve the isolation rate of leptospires from the kidneys of wild rats.


Subject(s)
Bacteriological Techniques/methods , Culture Media/chemistry , Leptospira interrogans/isolation & purification , Leptospirosis/veterinary , Rodent Diseases/diagnosis , Rodent Diseases/microbiology , Agglutination Tests , Animals , Cities , DNA Gyrase/genetics , Disease Models, Animal , Japan , Kidney/microbiology , Leptospira interrogans/pathogenicity , Leptospirosis/diagnosis , Leptospirosis/microbiology , Mesocricetus , Rats , Urine , Virulence
3.
Article in English | MEDLINE | ID: mdl-25605653

ABSTRACT

Rats are known to be the most important reservoirs of Leptospira spp. However, the leptospiral dose and age at which rats become resistant to Leptospira infection are not yet well elucidated. Aimed to characterize leptospirosis in rat pups, we found that suckling pups (4-, 7-, and 14-day old) are susceptible to leptospires and resistance starts from the weaning age (23-day old). Susceptibility of rat pups was also affected by the infecting dose of the organisms. Jaundice, decrease in body weight, and neurological symptoms prior to moribundity was evident in infected suckling pups. However, 23-day-old infected pups did not manifest any pathological changes and were able to survive the infection similar to adult rats. Based on these results, we propose the suckling rat pup as a novel animal model of human leptospirosis to investigate pathogenesis, development of host resistance, and the mechanisms involved in rats becoming maintenance hosts for leptospires.


Subject(s)
Disease Models, Animal , Leptospirosis/microbiology , Rats , Animals , Animals, Suckling , Host-Pathogen Interactions , Leptospira/pathogenicity , Leptospirosis/pathology , Weaning
4.
Microb Pathog ; 65: 57-62, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24120399

ABSTRACT

Previously, we reported that minocycline, kanamycin and norfloxacin improved the survival rate in the E32511 model that we developed (FEMS Immunol Med Microbiol 26, 101-108, 1999), but fosfomycin did not. In this study, we investigated the effectiveness of azithromycin (AZM) against Stx2d-producing EHEC O91:H21 strain B2F1 or Stx2c-producing Escherichia coli strain E32511 treated with mitomycin C in vivo. Recently, we reported the effectiveness of AZM in our model and AZM strongly inhibited the release of Stx2c from E32511 in vitro (PLOS ONE e58959, 2013). However, it was very difficult to completely eliminate E32511 in the mouse feces by treatment with AZM alone. In this report, only AZM or Daio effectively promoted survival of mice infected with B2F1 compared to untreated mice. Furthermore, Daio inhibited the colonization of GFP-expressing B2F1 in the mouse intestine. Similarly, a combination of AZM and Daio in the E32511-infected mice reduced E32511 in the mouse feces and significantly improved survival.


Subject(s)
Azithromycin/therapeutic use , Drugs, Chinese Herbal/therapeutic use , Escherichia coli O157/drug effects , Hemolytic-Uremic Syndrome/drug therapy , Shiga-Toxigenic Escherichia coli/drug effects , Animals , Anti-Bacterial Agents/therapeutic use , Colon/microbiology , Escherichia coli O157/pathogenicity , Feces/microbiology , Female , Medicine, Chinese Traditional , Mice , Mice, Inbred ICR , Microbial Sensitivity Tests , Mitomycin/pharmacology , Shiga Toxin 2/metabolism , Shiga-Toxigenic Escherichia coli/pathogenicity
5.
PLoS One ; 8(3): e58959, 2013.
Article in English | MEDLINE | ID: mdl-23516588

ABSTRACT

A large outbreak of Shiga toxin (Stx)-producing enteroaggregative Escherichia coli (EAEC) O104:H4 occurred in northern Germany. From this outbreak, at least 900 patients developed hemolytic uremic syndrome (HUS), resulting in more than 50 deaths. Thirty percent of the HUS patients showed encephalopathy. We previously established a mouse model with encephalopathy associated with blood brain barrier (BBB) damage after oral infection with the Shiga toxin (Stx) 2c-producing Escherichia coli O157: H- strain E32511 (E32511). In this model, we detected high expression of the Stx receptor synthase enzyme, glycosphingolipid globotriaosylceramide (Gb3) synthase, in endothelial cells (ECs) and neurons in the reticular formation of the medulla oblongata by in situ hybridization. Caspase-3 was activated in neurons in the reticular formation of the medulla oblongata and the anterior horn of the spinal cord. Astrocytes (ASTs) were activated in the medulla oblongata and spinal cord, and a decrease in aquaporin 4 around the ECs suggested that BBB integrity was compromised directly by Stx2c or through the activation of ASTs. We also report the effectiveness of azithromycin (AZM) in our model. Moreover, AZM strongly inhibited the release of Stx2c from E32511 in vitro.


Subject(s)
Escherichia coli Infections/complications , Neurotoxicity Syndromes/etiology , Neurotoxicity Syndromes/microbiology , Shiga-Toxigenic Escherichia coli/pathogenicity , Animals , Anti-Bacterial Agents/therapeutic use , Aquaporin 4/metabolism , Astrocytes , Azithromycin/therapeutic use , Blood-Brain Barrier , Caspase 3 , Endothelial Cells/enzymology , Female , Medulla Oblongata/cytology , Mice , Mice, Inbred ICR , Neurons/enzymology , Neurotoxicity Syndromes/drug therapy , Shiga-Toxigenic Escherichia coli/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...